RxDoctor Payments Data

Luciana Borio

Infectious Disease · Baltimore, MDNPI 1346206570

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $667,619 of the $671,349 with a category attached, or 99.4%. Insulet Corporation accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $299,889 and has fallen 69.5% since, to $91,446 in 2025. Among infectious disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$671,349in general payments, 2019–2025

Across 29 payments — averaging $23,150 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$671K
  • Regeneron$198

What the payments were for

  • Speaking & faculty fees$667,61999%
  • Travel & lodging$3,5321%
  • Food & beverage$1980%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insulet Corporation28$671,151
Regeneron1$198

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$671,349 in reported general payments places this provider in the 95th percentile of 289 infectious disease providers in Maryland.

See all infectious disease providers in Maryland

Other infectious disease in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →